Management of EGFR-Variant and ALK-Positive Non-Small Cell Lung Cancer Brain Metastasis. Pike LRG, Yu H, Rusthoven CG. JAMA Oncol 2025 Apr 3. doi: 10.1001/jamaoncol.2025.0188.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pike LRG, Yu H, Rusthoven CG. Management of EGFR-Variant and ALK-Positive Non-Small Cell Lung Cancer Brain Metastasis. JAMA Oncol 2025 Apr 3. doi: 10.1001/jamaoncol.2025.0188.
PMID: 40178832